CLARITY PHARMA RESEARCH ®
PHARMACEUTICAL MARKET RESEARCH REPORTS BASED IN SCIENCE ™
- A sample drawn by the previous supplier of a Hep C study conducted for a large pharmaceutical company in the US was made up of only 14% non-Caucasians. According to the CDC, non-Caucasians made up 35% of the Hep C cases of chronic HCV in the US in 2000. Thus, the previous supplier’s study was drawn from an incorrect sample.
- Both of our subsequent studies were composed of a representative sample that included the correct proportions.
Hep C Study Shows Why Sampling Matters
Our respondents mirrored actual US patient universe
© 2014-2022 Clarity Pharma Research® LLC | All Rights Reserved | Privacy Policy
To learn more about our services, contact information@claritypharma.com.
Subscribe to our newsletter at: http://eepurl.com/ovQcb